<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>14</Volume>
				<Issue>12</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Common Variants in the PALB2 Gene Confer Susceptibility to Breast Cancer: a Meta-analysis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>7149</FirstPage>
			<LastPage>7154</LastPage>
			<ELocationID EIdType="pii">28424</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objective&lt;/b&gt;: Increasing scientific evidence suggests that common variants in the PALB2 gene may confersusceptibility to breast cancer, but many studies have yielded inconclusive results. This meta-analysis aimed toderive a more precise estimation of the relationship between PALB2 genetic variants and breast cancer risk.&lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: An extensive literary search for relevant studies was conducted in PubMed, Embase, Web of Science,Cochrane Library, CISCOM, CINAHL, Google Scholar, CNKI and CBM databases from their inception throughSeptember 1st, 2013. A meta-analysis was performed using the STATA 12.0 software and crude odds ratios (ORs)with 95% confidence intervals (CIs) were calculated. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Six case-control studies were included with a totalof 4,499 breast cancer cases and 6,369 healthy controls. Our meta-analysis reveals that PALB2 genetic variantsmay increase the risk of breast cancer (allele model: OR&gt;1.36, 95%CI: 1.20~1.52, P &lt; 0.001; dominant model:OR&gt;1.64, 95%CI: 1.42~1.91, P &lt; 0.001; respectively). Subgroup analyses by ethnicity indicated PALB2 geneticvariants were associated with an increased risk of breast cancer among both Caucasian and Asian populations(all P &lt; 0.05). No publication bias was detected in this meta-analysis (all P &gt; 0.05). &lt;br/&gt;&lt;b&gt;Conclusion&lt;/b&gt;: The currentmeta-analysis indicates that PALB2 genetic variants may increase the risk of breast cancer. Thus, detection ofPALB2 genetic variants may be a promising biomarker approach.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">PALB2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">genetic variants</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28424_2e10ecaa9fa6c3f51f3ef953caae1ac8.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
